Compare ABVX & BILI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ABVX | BILI |
|---|---|---|
| Founded | 2013 | 2009 |
| Country | France | China |
| Employees | N/A | N/A |
| Industry | | EDP Services |
| Sector | | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.2B | 10.8B |
| IPO Year | N/A | 2018 |
| Metric | ABVX | BILI |
|---|---|---|
| Price | $114.30 | $35.85 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 7 |
| Target Price | ★ $130.09 | $30.00 |
| AVG Volume (30 Days) | 1.8M | ★ 3.5M |
| Earning Date | 08-11-2025 | 02-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.25 |
| Revenue | $6,231,374.00 | ★ $4,180,323,637.00 |
| Revenue This Year | $6.80 | $14.70 |
| Revenue Next Year | N/A | $9.47 |
| P/E Ratio | ★ N/A | $136.24 |
| Revenue Growth | N/A | ★ 16.95 |
| 52 Week Low | $4.77 | $14.47 |
| 52 Week High | $148.83 | $35.12 |
| Indicator | ABVX | BILI |
|---|---|---|
| Relative Strength Index (RSI) | 42.99 | 74.74 |
| Support Level | $113.64 | $32.64 |
| Resistance Level | $125.00 | $33.58 |
| Average True Range (ATR) | 7.79 | 1.13 |
| MACD | -0.80 | 0.42 |
| Stochastic Oscillator | 26.16 | 93.02 |
Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.
Bilibili is a Chinese online entertainment platform best known for its YouTube-like video-sharing site. Founded in 2009, it initially focused on long-form content centered around anime, comics, and gaming, catering primarily to Gen Z users. Over time, the platform has broadened its content offerings to include a wider range of interests, successfully attracting a more diverse audience beyond the Gen Z demographic.